Segluromet
Product Images NDC 50090-6231

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Segluromet (NDC 50090-6231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906231)

SEGLUROMET (ertugliflozin and metformin HCl) 7.5 mg/1000 mg tablet label from A-S Medication Solutions. The label includes storage instructions to store at 68 to 77 degrees Fahrenheit, protect from moisture, and keep in a dry place. It also states the package contains 60 tablets and includes a barcode and NDC number 50090-6231-0.*

FDA Label Image

Chemical Structure (Segluromet 01)

Chemical structure of the active ingredient in SEGLUROMET, as shown in the image. The diagram depicts the molecular arrangement, including rings and functional groups typical of the compound.*

FDA Label Image

Chemical Structure (Segluromet 02)

Chemical structure of metformin hydrochloride, showing the molecular arrangement of atoms including methyl groups, nitrogen, and hydrogen atoms, with an associated hydrochloride (HCl) moiety.*

FDA Label Image

Figure 1 (Segluromet 03)

A forest plot chart showing the geometric mean ratio with 90% confidence intervals (CI) of AUC and Cmax for sitagliptin 100 mg, metformin 1000 mg, glimepiride 1 mg, simvastatin 40 mg, and rifampin 600 mg compared to ertugliflozin alone at 15 mg single dose. The x-axis represents relative percentage values ranging from 50 to 150%.*

FDA Label Image

Figure 2 (Segluromet 04)

A forest plot showing the geometric mean ratio (90% confidence interval) for the pharmacokinetic parameters AUC and Cmax of various single-dose medications relative to concomitant medication alone. Medications include Sitagliptin 100 mg, Metformin 1000 mg, Glimepiride 1 mg, Simvastatin 40 mg, and Simvastatin Acid (administered as Simvastatin). The x-axis represents percentages relative to concomitant medication alone, with values and confidence intervals illustrated for each drug and parameter.*

FDA Label Image

Figure 3 (Segluromet 05)

A line graph depicting the mean percentage change from baseline in HbA1c levels over a 26-week period for three groups: placebo, Ertugliflozin 5 mg, and Ertugliflozin 15 mg. The x-axis represents weeks, and the y-axis shows the mean change in HbA1c. Data points decrease for both Ertugliflozin groups indicating a reduction in HbA1c, compared to minimal change in the placebo group, with sample sizes listed below the x-axis for each group at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.